Dr. Steven Fletcher’s new grant fuels collaborative training bridging chemistry and biology at UMSOP and UMBC.

Ryan Pearson’s team will explore how engineered nanoparticles can safely retrain the immune system to reduce allergic airway inflammation.

Computer modeling finds the most promising compounds and guides their transformation into drugs.

Study will explore how an antibiotic-resistant bacterium survives in the body and how that knowledge could lead to new, more effective treatments.

Researchers aim to improve chemotherapy by enhancing drug efficacy and reducing heart toxicity through dual activation of CAR and Nrf2 pathways.

New cohorts in PSC and PHSR arrive as the School launches curriculum updates and deepens its commitment to research and student success.

Researchers are developing a novel therapy using safe, drug-free nanoparticles to aid the body in fighting sepsis more effectively.

Ceremonies honor six academic programs and the next generation of health care leaders, researchers, and advocates .

Russell Weiner, PhD, FAAPS, shares insights on preanalytics in biopharmaceutical research and offers workshops on career development.

Pharmaceutical scientist’s career blends metallobiochemistry and mentorship.

Leadership role provides oversight for grant and contract submissions and identification of funding sources and initiates collaborative and translational research programs.

New study sheds light on how disease progression and biomolecular corona affect nanoparticle-mediated immune activation.